First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant

General Information
Clinical trials phase	Phases 1/2
Start date (estimated)	2025-10-01
End date (estimated)	2027-07-31
Clinical feature	Label sensorineural hearing loss Link http://purl.obolibrary.org/obo/DOID_10003 Description An inner ear disease that is characterized by hearing loss resulting from damage to the cochlea, auditory nerve and/or brainstem.
Administrative Information
NCT number	NCT07032038
ICTRP weblink	https://trialsearch.who.int/Trial2.aspx?TrialID=NCT07032038
Source weblink	https://clinicaltrials.gov/study/NCT07032038
Sponsors	Rinri Therapeutics
Cells
Which differentiated cell type is used	Label neural progenitor cell Link http://purl.obolibrary.org/obo/CL_0011020 Description An undifferentiated cell derived from a neural stem cell, with a limited capacity to self-renew (Dibajnia and Morshead, 2013) and the ability to generate multiple types of lineage-restricted progenitors, contributing to the formation of neurons, astrocytes, and oligodendrocytes.
Recruitment
Recruitment Status	Not yet recruiting
Estimated number of participants	20